Diagnostic ultrasound ( PDFDrive )

Index I-23
Exudate ascites, 506–507
Exudates, pleural, sonographic appearance of,
1702
F
Face
abnormalities of, craniosynostosis and,
1136–1138
midface abnormalities of, 1148–1153
Face, fetal. See also Midface abnormalities; Neck,
fetal; Orbits, fetal
embryology and development of, 1133–1134,
1134f
forehead abnormalities in, 1137f, 1139–1140,
1139b, 1140f–1141f
hemangiomas of, 1154, 1160f
HPE changes to, 1189, 1189b
lower, abnormalities of, 1153–1154
macroglossia as, 1153, 1153b, 1158f
micrognathia as, 1153–1154, 1158f
retrognathia as, 1153–1154
midface abnormalities of, 1148–1153
normal, sonography of, 1134–1135, 1135f
orbital abnormalities in, 1140–1143
routine sonographic views of, 1021, 1024f
sot tissue tumors of, 1154, 1160f
Facial nerve, pediatric, anatomy of, 1630
Falciform ligament, 77, 79f
pediatric, 1731, 1731f–1732f
Fallopian tube(s), 585–589
anatomy of, 565, 565f
carcinoma in, 589
hydrosalpinx of, 585–587, 587f
normal sonographic appearance of, 568
pediatric, torsion of, 1875–1876
PID and, 587–589, 588f
torsion of, 589
Falx sign, bright, in osteogenesis imperfecta type
II, 1392
Familial hypocalciuric hypercalcemia, primary
hyperparathyroidism distinguished from,
734
Familial juvenile nephronophthisis, 359
Familial paraganglioma syndromes,
pheochromocytomas with, 1826
Fanconi anemia, 1746
Fanconi pancytopenia, 1400, 1402f
Far ield, of beam, 8
Fasciitis
necrotizing, of perineum, 846–847
planter, injection for, 902, 904f
Fascioliasis, 176–178, 177f–178f
FAST. See Focused abdominal sonography for
trauma
FASTER. See First and Second Trimester
Evaluation of Risk
Fastigial point, 1189–1190
Fat, Crohn disease and creeping, 269, 271f
Fat necrosis
injectable steroid complications with,
901
simulating anterior abdominal wall hernias, 500,
502f
Fat-luid levels, in breast cysts, 775, 778f
Fatty liver, 91–92, 92f–93f
Fecal incontinence, anal endosonography in, 305,
305f
Fecaliths, in acute appendicitis, 1857, 1859f
Feet. See Foot
Feminization, testicular, 1368
dysplastic gonads and, 1899
primary amenorrhea in, 1887
Feminizing adrenal tumors, pseudoprecocious
puberty and, 1888
Femoral artery
common, 966
AVF of, 974f
normal appearance of, 966–967, 967f
pseudoaneurysms of, 973f
stenosis of, 969f
supericial, 966
bypass grat of, 975f
calciication of, 968, 970f
normal appearance of, 966–967
occlusion of, 967f, 969f
stenosis of, 969f, 971f
Femoral canal, as landmark for femoral hernias,
482, 485f
Femoral hernias, 471, 481–483. See also Hernia(s),
femoral
Femoral vein
bifurcation of, 980–981
common
as landmark for femoral hernias, 482, 485f
normal anatomy of, 500, 981f
ultrasound examination of, 982–983
compression of, normal, 982f
DVT in duplicated, detecting, 988, 988f
normal, 989f
phasicity, 459, 459f–460f
Femur, fetal
bowing of, 1380f
deiciency of, proximal focal, 1400, 1400f
hypoplasia of, in caudal regression,
1237–1238
length of
assessment of, 1378, 1379t, 1380f
BPD in heterozygous achondroplasia
compared to, 1398, 1398f
in gestational age determination, 1448, 1449f,
1449t
in second-trimester, 1023f
short, etiology of, 1381
subtrochanteric, absence of, 1400
“telephone receiver”, 1380f
Femur, head of, pediatric
avascular necrosis of, 1930
in DDH assessment, 1923
position of, in evaluation of infant at risk,
1927
in sonogram of hip from transverse/lexion view,
1927, 1928f
Femur-ibula-ulnar complex, 1400
Femur/foot length ratio, 1379
Femur-tibia-radius complex, 1400
Fertilization, cycle of, 1051, 1051f
Fetal akinesia sequence, 1401
Fetal alcohol syndrome, 1194
rhabdomyosarcoma associated with, 1908
Fetal artery, aberrant, sirenomelia from, 1238
Fetal Echocardiography, indications for, 1270–
1273, 1273b
Fetal endoscopic tracheal occlusion (FETO), 1264
Fetal ibronectin (FFN), 1501
Fetal growth restriction, echogenic bowel and,
1316
Fetal hemoglobin deicit, immune hydrops and,
1419. See also Hemoglobin, fetal
Fetal hydrops. See Hydrops, fetal
Fetal lobation, in kidneys, 317, 1781, 1781f
Fetal period, 1054
Fetal renal hamartomas, 1818–1820
Fetal therapy, cervical assessment and, 1505
FETO. See Fetal endoscopic tracheal occlusion
Fetomaternal transfusion, maternal serum
alpha-fetoprotein elevation in, 1228
Fetter syndrome, craniosynostosis in,
1136–1138
Fetus. See also speciic organs
adrenal glands of
masses in, 1353–1354, 1353f, 1353t
normal, 1353, 1353f
assessment of, for alloimmunization, 1421–1423,
1421b, 1422f, 1422t
assessment of well-being of, 1455–1460
BPP for, 1456–1458, 1457f, 1457t
Doppler ultrasound for, 1458–1460,
1459f–1460f
“Buddha position” of, 1401
coexistent hydatidiform molar pregnancy and,
1078–1080, 1081f
death of
echogenic bowel and, 1316
maternal serum alpha-fetoprotein elevation
in, 1228
deinition of, 1445
ears of
abnormalities of, 1148, 1148f
length of, in trisomy 21, 1101
low-set, 1148
foot of, deformities of, 1404–1407
gestational age determination and measurements
of, 1016, 1016b, 1444–1449
age assignment and, 1449, 1450t
in irst trimester, 1444–1445, 1445f–1446f,
1445t–1446t
in second and third trimesters, 1446–1448,
1447f–1450f, 1447t–1449t
growth of
abnormalities of, 1453–1455
assessment of, 1022–1029
curves depicting, 1453, 1453f
restriction of, 1455
growth restriction of, echogenic bowel and, 1316
hand of, deformities of, 1404–1407
keepsake imaging of, 49b, 50
large-for-gestational age, 1453–1454
diabetic mothers and, 1454, 1455t
incidence of, 1453–1454
sonographic criteria for, 1454t–1455t
malformations of, diagnostic accuracy of, 1030
megacystis in, 1360, 1360b, 1360f
movements of, musculoskeletal development
and, 1378
MRI of, 1031–1032, 1031f
presentation of, determination of, 1021, 1022f
situs of, determination of, 1021, 1022f
small-for-gestational age, 1454–1455, 1454b
sonographic appearance of, normal, 1018f
weight assessment for, 1450–1453
in relation to gestational age, 1451–1453,
1452t, 1453f
weight estimation for, 1450–1453
formulas in, 1451, 1451t
gestational age compared to, 1453, 1453f
recommended approach in, 1451, 1452t
FFN. See Fetal ibronectin
Fibrinous peritonitis, 509f
Fibroadenoma, 797, 797f
Fibrochondrogenesis, 1396
Fibroelastosis, endocardial, fetal, 1294, 1295f
heart block and, 1425
Fibroglandular tissue, asymmetrical, split-screen
imaging and, 769, 769f
Fibroids, uterine, 538–540, 539f, 540b
Fibrolamellar carcinoma, 122–123
Fibrolipomas, coccygeal dimples and, 1679
Fibroma(s)
cardiac, fetal, 1294
gastrointestinal, endosonographic identiication
of, 301
ovarian, 585, 586f
Volume I pp 1–1014 • Volume II pp 1015–1968